Literature DB >> 12198062

The effect of clonidine on the minimum local analgesic concentration of epidural ropivacaine during labor.

Chritophe Aveline1, Sonia El Metaoua, Anis Masmoudi, Pierre-Yves Boelle, Francis Bonnet.   

Abstract

UNLABELLED: On the basis of the determination of minimum local analgesic concentration (MLAC), ropivacaine has been demonstrated to be less potent than bupivacaine during the first stage of labor. In this study we assessed the effect of clonidine on the MLAC of ropivacaine. Seventy-seven parturients of mixed parity requesting epidural analgesia for labor (cervical dilation, 3-7 cm) were included in the study. They received an epidural bolus of either ropivacaine (n = 30), ropivacaine plus clonidine 30 microg (n = 28), or ropivacaine plus clonidine 60 microg (n = 19) in the second part of the study. The concentration of the ropivacaine solution was determined by the response of the previous parturient in that group by using an up-down sequential allocation. A visual analog pain score of < or =10 mm within 30 min after the epidural bolus (20 mL) was considered an effective response. An effective result directed a 0.01% wt/vol decrement for the next patient. An ineffective result directed a 0.01% wt/vol increment. The MLAC of ropivacaine was 0.097% wt/vol (95% confidence interval, 0.085%-0.108%). It was unaffected by a 30-microg dose of epidural clonidine (0.081% [0.045%-0.117%]) but was significantly decreased by a 60-microg clonidine dose (0.035% [0.024%-0.046%]) (P < 0.001). This study documents a decrease in the MLAC of ropivacaine by clonidine, significant for a 60- microg dose. IMPLICATIONS: Epidural ropivacaine potency in labor can be increased by the addition of epidural clonidine. This study demonstrates that 60 microg of epidural clonidine significantly decreases the minimum local analgesic concentration of ropivacaine during the first stage of labor but is associated with sedation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198062     DOI: 10.1097/00000539-200209000-00037

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Epidural clonidine added to a bupivacaine infusion increases analgesic duration in labor without adverse maternal or fetal effects.

Authors:  Robert K Parker; Neil Roy Connelly; Tanya Lucas; Stelian Serban; Rene Pristas; Evan Berman; Charles Gibson
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

4.  Transport of clonidine at cultured epithelial cells (JEG-3) of the human placenta.

Authors:  Johanna Müller; Reinhard Neubert; Matthias Brandsch
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

5.  Patient Controlled Epidural Labour Analgesia (PCEA): A Comparison Between Ropivacaine, Ropivacaine-Fentanyl and Ropivacaine-Clonidine.

Authors:  Arun Ahirwar; Ravi Prakash; Brij Bihari Kushwaha; Amrita Gaurav; Ajay Kumar Chaudhary; Reetu Verma; Dinesh Singh; Vineeta Singh
Journal:  J Clin Diagn Res       Date:  2014-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.